Takeaways from the AP's report on turmoil surrounding the FDA's new fast-track drug program

  • Posted on January 16, 2026
  • By The Toronto Star
  • 3 Views
Takeaways from the AP's report on turmoil surrounding the FDA's new fast-track drug program

WASHINGTON (AP) — A plan to slash drug review times at the Food and Drug Administration is sparking deep concerns among agency staffers and outside experts, with some saying the
continue reading...

Author
The Toronto Star

You May Also Like